Are SSRIs safe for pregnant and breastfeeding women?

Canadian Family Physician

Volumn 46, Issue MAR., 2000, Pages 626-633

  Misri, Shaila ^a   Burgmann, Allan ^b   Kostaras, Demetra ^b  

^a ST PAUL S HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; FLUVOXAMINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

BREAST FEEDING; DRUG SAFETY; FETUS; FETUS MALFORMATION; HUMAN; INFANT; LACTATION; PREGNANCY; PRENATAL DRUG EXPOSURE; REVIEW; RISK BENEFIT ANALYSIS;

ABNORMALITIES, DRUG-INDUCED; BREAST FEEDING; FEMALE; HUMANS; PREGNANCY; PREGNANCY COMPLICATIONS; RISK ASSESSMENT; SEROTONIN UPTAKE INHIBITORS;

EID: 0034062102     PISSN: 0008350X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Murray L, Cooper PJ. Postpartum depression and child development. Psychol Med 1997;27:253-60.
2. Caplan HL, Cogill SR, Alexandra H, Robson KM, Katz R, Kumar R. Maternal depression and the emotional development of the child. Br J Psychiatry 1989;154:818-22.
3. Steiner M, Yonkers K. Depression in women: mood disorders associated with reproductive cyclicity. London, UK: Martin Dunitz Ltd; 1998.
4. Cohen LS, Rosenbaum JF. Psychotropic drug use during pregnancy: weighing the risks. J Clin Psychiatry 1998;59(Suppl 2):18-25.
5. Field TM. Early interactions between infants and their postpartum depressed mothers. Infant Behav Dev 1984;7:517-22.
6. Cogill SR, Caplan HL, Alexandra H. Impact of maternal postnatal depression on cognitive development of young children. BMJ 1986;292:1165-7.
7. Field TM. Infants of depressed mothers. Infant Behav Dev 1995;18:1-13.
8. Longhurst JG, Weiss E. Use of psychotropic medications during lactation. Am J Psychiatry 1998;155(11):1643.
9. Altshuler LL, Szuba MP. Course of psychiatric disorders in pregnancy: dilemmas in pharmacologic management Neurol Clin North Am 1994;12:613-35.
10. Goldberg HL, Nissim R. Psychotropic drugs in pregnancy and lactation. Int J Psychiatry Med 1994;24:129-47.
11. Shader RI. Is there anything new on the use of psychotropic drugs during pregnancy? J Clin Psychopharmacol 1994;14:438.
12. Pastuszak A, Schick-Boschetto B, Zuber C, Feldkamp M, Pinnelli M, Sihn S, et al. Pregnancy outcome following first-trimester exposure to fluoxetine (Prozac). JAMA 1993;269:2246-8.
13. Chambers CD, Johnson KA, Dick LM, Felix RJ, Lyons Jones K. Birth outcomes in pregnant women taking fluoxetine. N Engl J Med 1996;335:1010-5.
14. Goldstein DJ, Corbin LA, Sundell KL Effects of first-trimester fluoxetine exposure on the newborn. Obstet Gynecol 1997;89(5 pt 1):713-8.
15. Mhanna MJ, Bennet JB II, Izatt SD. Potential fluoxetine chloride (Prozac) toxicity in an newborn. Pediatrics 1997;100(1):158-9.
16. Spencer MJ. Fluoxetine hydrochloride (Prozac) toxicity in a neonate. Pediatrics 1993;92:721-2.
17. Nulman I, Rovet J, Stewart DE, Wolpin J, Gardner HA, Theiss JGW, et al. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med 1997;336:258-62.
18. Weinberg MK, Tronick EZ. The impact of maternal psychiatric illness on infant development. J Clin Psychiatry 1998;59(Suppl 2):53-61.
19. Taddio A, Ito S, Koren G. Excretion of fluoxetine and its metabolite in human breast milk. J Clin Pharmacol 1996;36:42-7.
20. Yoshida K, Smith B, Craggs M, Channi Kumar R. Fluoxetine in breast-milk and developmental outcome of breast-fed infants. Br J Psychiatry 1998;172:175-9.
21. Isenberg KE. Excretion of fluoxetine in human breast milk [letter]. J Clin Psychiatry 1990;51:169.
22. Lester BM, Cucca J, Andreozzi L, Flanagan P. Possible association between fluoxetine HCl and colic in an infant J Am Acad Child Adolesc Psychiatry 1993;32:1253-5.
23. Brent NB, Wisner KL. Fuoxetine and carbamazepine concentrations in a nursing mother/infant pair. Clin Pediatr 1998;37:41-4.
24. Kent LSW, Laidlaw JDD. Suspected congenital sertraline dependence [letter]. Br J Psychiatry 1995;167:412-3.
25. Epperson CN, Anderson GM, McDougle CJ. Sertraline and breastfeeding [letter]. N Engl J Med 1997;336:1189-90.
26. Kulin NA, Pastuszak A, Sage SR, Schick-Boschetto B, Spivey G, Feldkamp M, et al. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors; a prospective controlled multicenter study. JAMA 1998;279:609-10.
27. Wisner KL, Perel JM, Blumer J. Serum sertraline and N-desmethylsertraline levels in breast-feeding mother-infant pairs. Am J Psychiatry 1998;155(5):690-2.
28. Stowe ZN, Owens MJ, Landry JC, Kilts CD, Ely T, Llewelyn A, et al. Sertraline and desmethylsertraline in human breast milk and nursing infants. Am J Psychiatry 1997;154(9):1255-60.
29. Mammen OK, Perel JM, Rudolph G, Foglia JP, Wheller SB. Sertraline and norsertraline levels in three breastfed infants. J Clin Psychiatry 1997;58:100-3.
30. Dahl ML, Olhager E, Ahlner J. Paroxetine withdrawal syndrome in a neonate. Br J Psychiatry 1997;171:391-2.
31. Stewart DE. Are there special considerations in the prescription of serotonin reuptake inhibitors for women? Can J Psychiatry 1998;43:9004.
32. Baum AL, Misri S. Selective serotonin-reuptake inhibitors in pregnancy and lactation. Harvard Rev Psychiatry 1996;4:117-25.